guidance

shutterstock_482109052 (1)

TGA deploys Post Market Review Compliance Dashboard

By Homi Dalal | 29 October 2020
Under the Therapeutic Goods Act 1989, it is mandatory for sponsors and manufacturers to report adverse events that have, or could have, led to death, serious illness or injury to...
Time Lapse

TGA Issues guidance for sponsors with lapsing Conformity Assessment Certificates

By Luis Jimenez | 19 October 2020
On 13 October 2020, the TGA specified that it will take a broader view in the case that companies suffer a lapse on renewing their Conformity Assessment Documents in response...
FDA

New Guidance on FDA ISO 10993-1

By James Morrison | 14 September 2020
On 4 September 2020 FDA re-issued their guidance on the use of ISO 10993-1 and Biocompatibility. I don’t think anyone saw this coming. It’s a big surprise! But the good...
End of financial year

Out They Go – FDA Clears the Store of Guidances

By Arthur Brandwood | 25 October 2019
In a now traditional clearing of the store, FDA issued a raft of new guidances at the close of the financial year. Through September to October 10 a total of...
Red carpet

FDA Fashion Parade – Guidance Priorities for Fiscal 2020

By Arthur Brandwood | 25 October 2019
Each new fiscal year, FDA sets out its priorities for guidance development and publication over the coming year. It’s always a fascinating insight into the current regulatory fashions, and just...

Search

Recent Posts

Clinical Evidence Insights for Medical Devices in China

Jan 22, 2021

EUDAMED is LIVE

Dec 15, 2020

MD Regulatory transition under Brexit

Dec 15, 2020

DOC’s will need to be submitted for new Class I IVD ARTG registrations

Nov 26, 2020

Formulated ingredients and premixes: Keeping the IP of a PI

Nov 24, 2020

TGA guidance for SaMD Regulatory “Carve Out”

Nov 19, 2020

Categories

Categories

Archives

Archives

Archives

Tags

510(k) ARTG Australia Biocompatibility Brexit CE CE Certificates China clinical evidence clinical trials Conformity Assessment coronavirus COVID-19 COVID19 de novo Drug EU Europe FDA guidance IVD IVDD IVDR IVDs MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines MHRA Pharmaceutical PMA PMDA postmarket Reform regulatory Reimbursement SaMD Software Software as a Medical Device (SaMD) standards TGA